NCT07804316Recruiting
Fostering Self-Empowerment in CKD Patients Through Food Choice Mapping
Fostering Self-Empowerment in Kidney Disease Patients Through Food Choice Mapping: A Pilot Study
Source: ClinicalTrials.gov · Last updated 4 Sept 2026
Brief summary (registry, in English)
This project aims to develop mapping of food choices available for chronic kidney disease (CKD) patients when dining out in Singapore. Following the mapping, a mobile application will be developed based on renal dining out food map mobile application (RENDOFOMAP) and trialed on patients with CKD. The specific aims of the project include: 1. Mapping out food choices suitable for patients with CKD when dining out in Singapore which will eventually be translated into a mobile application incorporating simple AI functionality. 2. To evaluate the impact of using RENDOFOMAP on self-empowerment, quality of life, nutritional status, and serum biochemistry in patients with CKD. 3. To evaluate the acceptability and user experience of RENDOFOMAP Participants with CKD will use the newly developed mobile application to find out if there is improvement in self-empowerment, quality of life, nutritional status, and serum biochemistry.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 30 (estimated)
- First submitted
- 19 Jul 2026
- Start date
- 15 Apr 2026
- Primary completion date
- 16 Jan 2027
- Lead sponsor
- Singapore Institute of Technology
- Diseases
- Chronic kidney disease
- NCT number
- NCT07804316
What you commit to
- Study type: Observational
- Planned participants: 30
- From 15 Apr 2026 to the primary completion date, 16 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Diagnosis of cognitive deficit or neurological disorder. These conditions could impair the ability to follow study procedures or provide reliable data.
- Newly initiated on dialysis or planning for dialysis within the next 6 months. These patients may have rapidly changing health conditions that could affect study outcomes.
- Decompensated liver cirrhosis. This condition could complicate the interpretation of study results.
- Pregnant and lactating. These conditions could introduce additional variables that affect study outcomes.
Lab values
- Uncontrolled diabetes (HbA1c\>8.5%). This condition could introduce additional health risks and confound study results.
Other
- Only fluent in languages other than English. This could hinder effective communication and understanding of the study.
- Recent hypoglycemic episodes. This could pose a safety risk during the study.
- Inability to provide consent. This ensures that all participants can legally and ethically participate in the study
Who the study is looking for
- Are fluent in English. This is necessary to ensure clear communication and understanding of study procedures and materials.
- Adequate proficiency in using smartphone i.e. downloading app, taking photo, completing e-forms within the mobile applications. This is essential for participants to effectively use the mobile application being tested.
- Diagnosed with CKD Stage 3B-5. This targets the specific patient population that the study aims to benefit.
Age in the registry: 21 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Singapore Institute of Technology Coordinator of this site? Confirm its status | Singapore | Singapore | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.